Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications assessment inter intra rater reliability objective cough frequency patients chronic
… to drug manufacturers. The Patient-Centered Outcomes Assessment team at RTI Health Solutions has analyzed FDA PRO … Access and Outcomes Strategy Patient-Centered Outcomes Assessment Staff Members Carla DeMuro Ari Gnanasakthy …
… Lori McLeod Patient-Centered Outcomes Assessment Pain Oncology Diabetes & Endocrine Disorders … psychometric evaluations including the assessment of scale reliability, validity, responsiveness, and work to define … in a wide variety of therapeutic areas, including chronic pain, neurology, oncology, psychiatry, respiratory, …
Webinar: Characteristics of Recent PRO Labeling by the FDA and EMA for Oncology Drugs Share on: Wednesday, March 13 - Thursday, March 14, 2019 Watch the Recording Trends in EMA and FDA Labeling Based on Patient-Reported Outcomes (PROs) A recent review of …
ISPOR Europe 2023 Share on: Sunday, November 12 - Wednesday, November 15, 2023 Conference website HEOR at the Nexus of Policy and Science Many of our researchers will be in Copenhagen and would love to chat with you. You can find them at the RTI Health …
… meaningful insights. RTI’s uncompromisingly ethical and objective researchers ensure that results will hold up to … Clients rely on us to answer questions that demand an objective and multidisciplinary approach — one that …
Webinar: Addressing Challenges in Health Equity Research Share on: Wednesday, November 8, 2023, 12 - 1pm Register Now Methods and Tools to Support Actionable Health Equity Research for the Biomedical Sciences Health equity is gaining increased interest …
… Sandy Lewis Patient-Centered Outcomes Assessment Respiratory Psychiatry Ophthalmology Medical … Lewis is a Senior Director of Patient-Centered Outcomes Assessment at RTI-HS. She has more than 25 years of … She has supported the development and implementation of rater certification programs. During her tenure at Merck, Ms. …
… decreases in the efficacy of platelets, which meant that patients needed significantly more PC units for transfusion …
… for the treatment of numerous rare disease indications (chronic inflammatory demyelinating polyneuropathy (CIDP), …
HTA and Reimbursement Submissions The reimbursement environment is constantly changing. Requirements vary between markets and need coordination across multiple areas to produce high-quality results. To help you achieve market access, our experts across …